GlaxoSmithKline's IV drug for COVID-19 should no longer be used because it is likely ineffective against the omicron subvariant that now accounts for most U.S. cases, federal health regulators said Tuesday.
Apr 5, 2022
0
4
"OMG. Have you guys heard about this?"
Apr 5, 2022
0
2
Fresh government data shows that COVID deaths among nursing home residents data have fallen to the lowest levels seen since the pandemic began.
Apr 5, 2022
0
8
No one gave a second thought to the safety of dining out before the pandemic. Fast-forward to today, and it's normal to wonder whether there is a city, state or federal policy around whether you need a mask or proof of vaccination ...
Apr 4, 2022
0
24
The U.S. Food and Drug Administration announced Tuesday that it has approved a second booster shot of the Pfizer and Moderna coronavirus vaccines for people 50 and older.
Mar 29, 2022
0
4
Despite not knowing how long another jab might provide protection, the Biden administration plans to offer a second COVID booster shot to Americans 50 and older.
Mar 28, 2022
0
71
The COVID-related death rate among Americans who received Johnson & Johnson's COVID-19 vaccine was more than double that of people who received other vaccines, new data from the Omicron surge show.
Mar 26, 2022
1
322
At-home COVID-19 tests are a key tool in containing the spread of the coronavirus. But a few safety precautions are in order to prevent serious injury, the U.S. Food and Drug Administration warns.
Mar 22, 2022
0
12
COVID-19 antibody drugs from Regeneron and Eli Lilly should no longer be used because they don't work against the omicron variant that now accounts for nearly all U.S. infections, U.S. health regulators said Monday.
Jan 25, 2022
0
2
The U.S. Food and Drug Administration may soon curtail the use of two monoclonal antibody treatments that do not appear to work against the highly contagious Omicron variant.
Jan 24, 2022
0
10
